We are delighted to launch a new report, Misunderstood and Underserved, summarising the key findings of a 2023 patient experience survey and key recommendations for policymakers. You may recall this project has been developed in collaboration between Immunodeficiency UK and Takeda UK Limited. Both Immunodeficiency UK and Takeda UK Limited have provided input into the development
A new report: *Beyond the Pandemic: Strengthening Access to COVID-19 Therapies for High-Risk Patients in England, has revealed significant regional inequalities in access to life-saving COVID-19 treatments for clinically vulnerable people. Immunodeficiency UK contributed to the report. This report expands on the topics covered in their previous report: Beyond the pandemic: Addressing disparities in timely
IMPORTANT NOTE: The information contained on this website is intended only as a guideline, not as a substitute for medical advice. Always consult your doctor
if you or your child has any immunodeficiency symptoms or concerns. © 2025 Immunodeficiency UK. All rights reserved | Registered charity number 1193166.
